Level Chart

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 3.798B, up from 3.345B one year ago. This is a change of 13.54% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 3.798B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 95.36%
Value from 1 Year Ago 3.345B
Change from 1 Year Ago 13.54%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 3.798B
December 31, 2022 3.345B
December 31, 2021 3.361B
December 31, 2020 2.462B
December 31, 2019 1.793B
December 31, 2018 1.14B
Date Value
December 31, 2017 605.00M
December 31, 2016 113.10M
December 31, 2015 0.00
December 31, 2014 0.00
December 31, 2013 0.00
December 31, 2012 0.00

Basic Info

Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 3.798B, up from 3.345B one year ago. This is a change of 13.54% from one year ago.

Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 3.798B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 95.36%
Value from 1 Year Ago 3.345B
Change from 1 Year Ago 13.54%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -2.77%